Actinium Pharmaceuticals, Inc. , a leader in the development of differentiated targeted radiotherapies, today announced compelling preclinical data for ATNM-400, a first-in-class Actinium-225 (AC-225) ...
Tissue expansion, originally developed for super-resolution imaging, has become a foundation for expansion omics (ExO), a ...
Hockey Canada named their final 25-player roster ahead of the Canadian leg of the 2025 Rivalry Series to be played in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback